BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 22065564)

  • 41. Virtual reality exposure in the treatment of social phobia.
    Klinger E; Légeron P; Roy S; Chemin I; Lauer F; Nugues P
    Stud Health Technol Inform; 2004; 99():91-119. PubMed ID: 15295148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A survey on virtual environment applications to fear of public speaking.
    Vanni F; Conversano C; Del Debbio A; Landi P; Carlini M; Fanciullacci C; Bergamasco M; Di Fiorino A; Dell'Osso L
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1561-8. PubMed ID: 23832719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maximizing the impact of virtual reality exposure therapy for anxiety disorders.
    Anderson PL; Molloy A
    Curr Opin Psychol; 2020 Dec; 36():153-157. PubMed ID: 33176268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Virtual reality exposure therapy for social anxiety disorder: a systematic review and meta-analysis.
    Horigome T; Kurokawa S; Sawada K; Kudo S; Shiga K; Mimura M; Kishimoto T
    Psychol Med; 2020 Nov; 50(15):2487-2497. PubMed ID: 33070784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive mechanisms underlying virtual reality exposure.
    Côté S; Bouchard S
    Cyberpsychol Behav; 2009 Apr; 12(2):121-9. PubMed ID: 19250009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Virtual reality cognitive-behavior therapy for public speaking anxiety: one-year follow-up.
    Safir MP; Wallach HS; Bar-Zvi M
    Behav Modif; 2012 Mar; 36(2):235-46. PubMed ID: 22180390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Creating state of the art, next-generation Virtual Reality exposure therapies for anxiety disorders using consumer hardware platforms: design considerations and future directions.
    Lindner P; Miloff A; Hamilton W; Reuterskiöld L; Andersson G; Powers MB; Carlbring P
    Cogn Behav Ther; 2017 Sep; 46(5):404-420. PubMed ID: 28270059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anxiety-control strategies: is there room for neutralization in successful exposure treatment?
    Parrish CL; Radomsky AS; Dugas MJ
    Clin Psychol Rev; 2008 Dec; 28(8):1400-12. PubMed ID: 18783862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Documenting the efficacy of virtual reality exposure with psychophysiological and information processing measures.
    Côté S; Bouchard S
    Appl Psychophysiol Biofeedback; 2005 Sep; 30(3):217-32. PubMed ID: 16167187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Virtual reality exposure therapy for social anxiety disorder: a randomized controlled trial.
    Anderson PL; Price M; Edwards SM; Obasaju MA; Schmertz SK; Zimand E; Calamaras MR
    J Consult Clin Psychol; 2013 Oct; 81(5):751-60. PubMed ID: 23796315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of cognitive behavioral therapy for anxiety disorders: a review of meta-analytic findings.
    Olatunji BO; Cisler JM; Deacon BJ
    Psychiatr Clin North Am; 2010 Sep; 33(3):557-77. PubMed ID: 20599133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The application of virtual reality in the treatment of mental disorders].
    Tsamitros N; Beck A; Sebold M; Schouler-Ocak M; Bermpohl F; Gutwinski S
    Nervenarzt; 2023 Jan; 94(1):27-33. PubMed ID: 36053303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolating the effect of Virtual Reality Based Exposure Therapy for agoraphobia: a comparative trial.
    Malbos E; Rapee RM; Kavakli M
    Stud Health Technol Inform; 2011; 167():45-50. PubMed ID: 21685640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging treatments for PTSD.
    Cukor J; Spitalnick J; Difede J; Rizzo A; Rothbaum BO
    Clin Psychol Rev; 2009 Dec; 29(8):715-26. PubMed ID: 19800725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Virtual reality assisted cognitive behavioral therapy for the treatment of Panic Disorders with Agoraphobia.
    Vincelli F; Choi H; Molinari E; Wiederhold BK; Bouchard S; Riva G
    Stud Health Technol Inform; 2002; 85():552-9. PubMed ID: 15458151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Feasibility trial of virtual reality exposure therapy for selective mutism.
    Tan YR; Ooi YP; Ang RP; Goh DH; Kwan C; Fung DS; Sung SC
    Clin Child Psychol Psychiatry; 2022 Apr; 27(2):351-368. PubMed ID: 34866415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomised wait-list controlled pilot trial of one-session virtual reality exposure therapy for blood-injection-injury phobias.
    Jiang MYW; Upton E; Newby JM
    J Affect Disord; 2020 Nov; 276():636-645. PubMed ID: 32871696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current status of virtual reality exposure therapy in anxiety disorders: editorial review.
    Pull CB
    Curr Opin Psychiatry; 2005 Jan; 18(1):7-14. PubMed ID: 16639177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do self-statements enhance the effectiveness of virtual reality exposure therapy? A comparative evaluation in acrophobia.
    Krijn M; Emmelkamp PM; Olafsson RP; Schuemie MJ; van der Mast CA
    Cyberpsychol Behav; 2007 Jun; 10(3):362-70. PubMed ID: 17594260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of virtual reality exposure therapy for treatment of dental phobia: a randomized control trial.
    Raghav K; Van Wijk AJ; Abdullah F; Islam MN; Bernatchez M; De Jongh A
    BMC Oral Health; 2016 Feb; 16():25. PubMed ID: 26920573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.